Blood test for Alzheimer's goes on sale without FDA approval
St. Louis-based C2N Diagnostics has released a blood test that it says can detect Alzheimer's disease. The test is not yet FDA approved, and is not covered by insurance, costing up to $1,250. Northwell Health internal medicine specialist Dr. Karen Abrashkin joins CBSN's Anne-Marie Green to talk about the latest development in the fight against Alzheimer's, which affects nearly 6 million Americans.
UP NEXT
UP NEXT
-
Jobless claims dip to 900,000 in final week of Trump administration
CBS News
-
Biden signing new executive orders to address coronavirus pandemic
CBS News
-
Congressman: America "needs to see leaders like Vice President Harris"
CBS News
-
State governments voice concerns over COVID-19 vaccine rollout
CBS News
-
Maryland man accused of beating police with bat during Capitol riot
CBS News
-
Another 900,000 Americans filed new jobless claims last week
CBS News
-
Expert says Biden's presidency creates opportunity for China and U.S. to reengage with each other
CBS News
-
Biden administration gets to work on reversing Trump-era immigration policies
CBS News
-
Sneak peek: The 30-Year Secret – The Tracey Harris Murder
CBS News
-
States report they are running out of vaccines, cancelling appointments
CBS News
-
Nation's oldest African American sorority celebrates Kamala Harris' new role as vice president
CBS News
-
President Biden's COVID-19 plan covers vaccine and PPE shortages and reopening schools
CBS News
-
QAnon believers hit with disappointment after President Biden's inauguration
CBS News
-
Rock 'n' roll legend John Fogerty on new protest song tackling police brutality, racism
CBS News
-
President Biden focusing on COVID-19 response in his first full day in office
CBS News
-
WorldView: Deadly gas explosion in Madrid; police chief removed in Philippines
CBS News